GM
Therapeutic Areas
Delcath Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HEPZATO KIT™ (melphalan/HDS) | Metastatic Uveal Melanoma (mUM) | Approved |
| Melphalan/HDS | Metastatic Colorectal Cancer (mCRC) with liver-dominant disease | Phase 2 |
| Melphalan/HDS + Ipilimumab & Nivolumab | Metastatic Uveal Melanoma (mUM) | Phase 2 |